These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22387255)

  • 1. Nonalcoholic fatty liver disease and cardiovascular disease risk.
    Brown TM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):568-9. PubMed ID: 22387255
    [No Abstract]   [Full Text] [Related]  

  • 2. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
    Stepanova M; Younossi ZM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
    Santos RD; Valenti L; Romeo S
    Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and cardiovascular disease risk.
    Schindhelm RK; Diamant M; Heine RJ
    Curr Diab Rep; 2007 Jun; 7(3):181-7. PubMed ID: 17547835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk?
    Montecucco F; Mach F
    Endocr Metab Immune Disord Drug Targets; 2008 Dec; 8(4):301-7. PubMed ID: 19075784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based screening programs for nonalcoholic fatty liver disease in youth and clues to prevention.
    Manco M
    J Clin Endocrinol Metab; 2014 Mar; 99(3):774-6. PubMed ID: 24823704
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease and its association with cardiovascular disease.
    Lizardi-Cervera J; Aguilar-Zapata D
    Ann Hepatol; 2009; 8 Suppl 1():S40-3. PubMed ID: 19381123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.
    Pacana T; Fuchs M
    Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?
    Oni ET; Agatston AS; Blaha MJ; Fialkow J; Cury R; Sposito A; Erbel R; Blankstein R; Feldman T; Al-Mallah MH; Santos RD; Budoff MJ; Nasir K
    Atherosclerosis; 2013 Oct; 230(2):258-67. PubMed ID: 24075754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis.
    Alkhouri N; Kistangari G; Campbell C; Lopez R; Zein NN; Feldstein AE
    Hepatology; 2012 Jan; 55(1):331. PubMed ID: 21969091
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease and cardiovascular risk: is there a place for obstructive sleep apnea?
    Mirrakhimov AE; Mirrakhimov EM
    Can J Cardiol; 2013 Sep; 29(9):1139.e7. PubMed ID: 23265092
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis in obese adolescents: a looming marker of cardiac dysfunction.
    Santoro N; Caprio S
    Hepatology; 2014 Feb; 59(2):372-4. PubMed ID: 23913480
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Mirrakhimov and Mirrakhimov--nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
    Alp H
    Can J Cardiol; 2013 Sep; 29(9):1139.e9. PubMed ID: 23352427
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients.
    Ghamar-Chehreh ME; Khedmat H; Amini M; Taheri S
    Acta Med Iran; 2013 May; 51(5):307-13. PubMed ID: 23737314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nonalcoholic fatty liver disease and psoriasis].
    Rivera R; Vanaclocha F
    Actas Dermosifiliogr; 2010 Oct; 101(8):657-8. PubMed ID: 20965008
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.
    Sánchez-Jiménez BA; Brizuela-Alcántara D; Ramos-Ostos MH; Alva-López LF; Uribe-Esquivel M; Chávez-Tapia NC
    Alcohol; 2018 Jun; 69():63-67. PubMed ID: 29660603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis.
    Perseghin G
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S367-70. PubMed ID: 21525484
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences.
    Del Ben M; Baratta F; Polimeni L; Angelico F
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S291-6. PubMed ID: 23073870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP; Park SJ; Harrison SA
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.